{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T01:37:42Z","timestamp":1750469862304},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T00:00:00Z","timestamp":1442361600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13256-015-0674-9","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T09:40:10Z","timestamp":1442396410000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Inclusion body myositis in a patient with chronic myeloid leukemia treated with dasatinib: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Naif I.","family":"AlJohani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Carette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey H.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,16]]},"reference":[{"key":"674_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zoo Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9\u201329.","journal-title":"CA Cancer J Clin"},{"key":"674_CR2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1124\/mol.105.020172","volume":"69","author":"Z Chen","year":"2006","unstructured":"Chen Z, Lee FY, Bhalla KN, Wu J. Potent inhibition of platelet-derived growth factor-induced responses in vascular smooth muscle cells by BMS-354825 (Dasatinib). Mol Pharmacol. 2006;69:1527\u201333.","journal-title":"Mol Pharmacol"},{"key":"674_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1182\/blood-2005-10-3969","volume":"108","author":"NP Shah","year":"2006","unstructured":"Shah NP, Lee FY, Luo R, Jiang Y, Donker M, Akin C. Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis. Blood. 2006;108:286\u201391.","journal-title":"Blood"},{"key":"674_CR4","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1056\/NEJMoa055229","volume":"354","author":"M Talpaz","year":"2006","unstructured":"Talpaz M, Shah NP, Kantarjian H, Donato N, Nicoll J, Paquette R, et al. Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias. N Engl J Med. 2006;354:2531\u201341.","journal-title":"N Engl J Med"},{"key":"674_CR5","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1182\/blood-2007-02-073528","volume":"110","author":"O Ottmann","year":"2007","unstructured":"Ottmann O, Dombret H, Martinelli G, Simonsson B, Guilhot F, Larson RA, et al. Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study. Blood. 2007;110:2309\u201315.","journal-title":"Blood"},{"key":"674_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1158\/1078-0432.CCR-07-4175","volume":"14","author":"M Brave","year":"2008","unstructured":"Brave M, Goodman V, Kaminskas E, Farrell A, Timmer W, Pope S, et al. Sprycel for chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to or intolerant of imatinib mesylate. Clin Cancer Res. 2008;14:352\u20139.","journal-title":"Clin Cancer Res"},{"key":"674_CR7","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3109\/10428194.2012.656626","volume":"53","author":"GH Rodriguez","year":"2012","unstructured":"Rodriguez GH, Ahmed SI, Al-Akhrass F, Rallapalli V, Safdar A. Characteristics of, and risk factors for, infections in patients with cancer treated with dasatinib and a brief review of other complication. Leuk Lymphoma. 2012;53:1530\u20135.","journal-title":"Leuk Lymphoma"},{"key":"674_CR8","unstructured":"Patient Information. [ http:\/\/packageinserts.bms.com\/pi\/pi_sprycel.pdf ]"},{"key":"674_CR9","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1056\/NEJMoa1002315","volume":"362","author":"H Kantarjian","year":"2010","unstructured":"Kantarjian H, Shah NP, Hochhaus A, Cortes J, Shah S, Ayala M, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2010;362:2260\u201370.","journal-title":"N Engl J Med"},{"key":"674_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ccr3.5","volume":"1","author":"H Spechbach","year":"2013","unstructured":"Spechbach H, Morel P, Lorenzini KI, Besson M, Getaz L, Sunthorn H, et al. Reversible ventricular arrhythmia induced by dasatinib. Clin Case Reports. 2013;1:20\u20135.","journal-title":"Clin Case Reports"},{"key":"674_CR11","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1056\/NEJMc0708896","volume":"358","author":"N Penel","year":"2008","unstructured":"Penel N, Blay J-Y, Adenis A. Imatinib as a possible cause of severe rhabdomyolysis. N Engl J Med. 2008;358:2746\u20137.","journal-title":"N Engl J Med"},{"key":"674_CR12","unstructured":"DailyMed current medication information. [ http:\/\/dailymed.nlm.nih.gov\/dailymed\/archives\/fdaDrugInfo.cfm?archiveid=9440 ]"},{"key":"674_CR13","unstructured":"Cancer Care Online. Dasatinib Monograph. [ http:\/\/www.cancercare.on.ca\/CCO_DrugFormulary\/pages\/DfPdfContent.aspx?cat=DM&name=dasatinib ]"},{"key":"674_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.leukres.2009.11.002","volume":"34","author":"JK Gordon","year":"2010","unstructured":"Gordon JK, Magid SK, Maki RG, Fleisher M, Berman E. Elevations of creatine kinase in patients treated with imatinib mesylate (Gleevec). Leuk Res. 2010;34:827\u20139.","journal-title":"Leuk Res"},{"key":"674_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/bdrc.10030","volume":"69","author":"C Betsholtz","year":"2003","unstructured":"Betsholtz C. Biology of platelet-derived growth factors in development. Birth Defects Res (Part C). 2003;69:272\u201385.","journal-title":"Birth Defects Res (Part C)"},{"key":"674_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.1414","volume":"201","author":"Y Zhao","year":"2003","unstructured":"Zhao Y, Haginoya K, Sun G, Dai H, Onuma A, Iinuma K. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study. J Pathol. 2003;201:149\u201359.","journal-title":"J Pathol"},{"key":"674_CR17","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/WNL.55.9.1385","volume":"55","author":"UA Badrising","year":"2000","unstructured":"Badrising UA, Maat-Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology. 2000;55:1385\u20137.","journal-title":"Neurology"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-015-0674-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T16:23:45Z","timestamp":1475511825000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-015-0674-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,16]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["674"],"URL":"https:\/\/doi.org\/10.1186\/s13256-015-0674-9","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,16]]},"article-number":"214"}}